Image

Ultrasound-guided Peripheral Intravenous Catheter Placement in an Oncologic Emergency Department - a Prospective, Randomized Controlled Trial of Catheter Lengths

Ultrasound-guided Peripheral Intravenous Catheter Placement in an Oncologic Emergency Department - a Prospective, Randomized Controlled Trial of Catheter Lengths

Recruiting
18 years and older
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

To learn about the effects of the length of the catheter on the failure and success rate of USIV placement.

Description

Primary Objectives:

  • The rate of catheter failure, defined as removal of the catheter for any reason other than "Care Complete" (i.e. a composite of removal due to "infiltration," "leaking," "catheter damage," "occlusion"), by day 10.

Secondary Objectives:

  1. Time from catheter placement to removal (i.e. survival or dwell time).
  2. Per catheter length rate of failure analysis
  3. Rate of repeat catheterization
  4. Rate of infection
  5. Rate of thrombosis

Eligibility

Inclusion Criteria:

  1. Age > 18 years old.
  2. Provision of signed and dated informed consent form.
  3. Predetermined to have difficult IV access necessitating USIV placement
  4. Expected admission to hospital with anticipated stay > 48 hours (per discussion with treating physician).

Exclusion Criteria:

  1. Expected/anticipated discharge disposition from the ACCC (per discussion with treating physician).
  2. Inability to give informed consent.
  3. Pregnant women.
  4. Non-English speaking participants.

Study details
    Oncologic Complications and Emergencies

NCT06217783

M.D. Anderson Cancer Center

2 July 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.